Canada Newborn Screening Market Size & Outlook, 2025-2033
Related Markets
Canada newborn screening market highlights
- The Canada newborn screening market generated a revenue of USD 19.0 million in 2024 and is expected to reach USD 38.8 million by 2033.
- The Canada market is expected to grow at a CAGR of 8.4% from 2025 to 2033.
- In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2024.
- Tandem Mass Spectrometry is the most lucrative technology segment registering the fastest growth during the forecast period.
Newborn screening market data book summary
| Market revenue in 2024 | USD 19.0 million |
| Market revenue in 2033 | USD 38.8 million |
| Growth rate | 8.4% (CAGR from 2025 to 2033) |
| Largest segment | Tandem mass spectrometry |
| Fastest growing segment | Tandem Mass Spectrometry |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis |
| Key market players worldwide | Bio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp |
Other key industry trends
- In terms of revenue, Canada accounted for 2.1% of the global newborn screening market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. newborn screening market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 38.8 million by 2033.
Tandem mass spectrometry was the largest segment with a revenue share of 26.84% in 2024. Horizon Databook has segmented the Canada newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2021 to 2033.
Unlike the extreme awareness levels witnessed in the U.S., Canada is still lagging in its efforts towards newborn screening program. Officially, Canada has no national standards set for screening of neonates and uses the ones established by the U.S. Mandated screening is applicable on only two conditions of those listed in the RUSP, which are congenital hypothyroidism and phenylketonuria.
However, in an attempt to change the scenario, Canadian Newborn and Child Screening Symposium held in May 2015 at Ontario highlighted the upcoming plans for the next five years. A few pointers of the plan are increasing involvement in innovation for newborn screening, collaborations, and tie-ups between industry representatives, clinicians, and market players and formation of uniform policies and standards.
Assisted regional growth can be witnessed over the next few years due to the market player PerkinElmer, which has commercially introduced the product range, EnLite, for Severe Combined Immunodeficiency (SCID) in December 2014
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Newborn Screening Market Scope
Newborn Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Covidien | View profile | 10001+ | Dublin, Dublin, Ireland, Europe | http://www.covidien.com |
| Natus Medical | View profile | 1001-5000 | San Carlos, California, United States, North America | http://www.natus.com |
| Agilent Technologies | View profile | 10001+ | Santa Clara, California, United States, North America | http://www.agilent.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Masimo Corp | View profile | 3796 | 52 Discovery, Irvine, CA, United States, 92618 | https://www.masimo.com |
| Waters Corp | View profile | 7900 | 34 Maple Street, Milford, MA, United States, 01757 | https://www.waters.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
Canada newborn screening market size, by technology, 2021-2033 (US$M)
Canada Newborn Screening Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
